Autoimmune hemolytic anemia (AIHA) is a type of
hemolytic anemia where the body's immune system attacks its own
red blood cells (RBCs), leading to their destruction (
hemolysis).
Antibodies and associated
complement system components become fixed onto the
RBC surface. These
antibodies can be detected with the
direct antiglobulin test, also known as the direct
Coombs test. AIHA can also be induced by several drugs including
methyldopa and
fludarabine.
Autoimmunity must not be confused with alloimmunity.
Classification
Haemolysis can be intravascular or extravascular.
Intravascular haemolysis
Red blood cell lysis occurs in the circulation as a result of activation of the complement system cascade.
Extravascular haemolysis
Red Blood Cells that are coated with antibodies are specifically recognised in the reticuloendothelial system and destroyed by macrophages.
Subtypes
Warm antibody autoimmune hemolytic anemia
Cold antibody autoimmune hemolytic anemia
Mixed-type autoimmune hemolytic anemia
Laboratory findings
See also
References
External links